Interdependence of Cell Growth and Gene Expression : Origins and Consequences

982 (2002). 4. I. C. MacLennan, Annu. Rev. Immunol. 12, 117 (1994). 5. A. Strasser, P. J. Jost, S. Nagata, Immunity 30, 180 (2009). 6. Y. Takahashi, H. Ohta, T. Takemori, Immunity 14, 181 (2001). 7. Z. Hao et al., Immunity 29, 615 (2008). 8. Y. Takahashi et al., J. Exp. Med. 190, 399 (1999). 9. K. G. Smith, U. Weiss, K. Rajewsky, G. J. Nossal, D. M. Tarlinton, Immunity 1, 803 (1994). 10. K. G. Smith et al., J. Exp. Med. 191, 475 (2000). 11. S. F. Fischer et al., Blood 110, 3978 (2007). 12. Materials and methods are available as supporting material on Science Online. 13. U. Klein et al., Proc. Natl. Acad. Sci. U.S.A. 100, 2639 (2003). 14. T. Yokoyama et al., Immunol. Lett. 81, 107 (2002). 15. K. Kwon et al., Immunity 28, 751 (2008). 16. M. Muramatsu et al., Cell 102, 553 (2000). 17. N. Motoyama et al., Science 267, 1506 (1995). 18. K. U. Wagner et al., Development 127, 4949 (2000). 19. A. Ridderstad, D. M. Tarlinton, J. Immunol. 160, 4688 (1998). 20. A. Radbruch et al., Nat. Rev. Immunol. 6, 741 (2006). 21. K. G. Smith, A. Light, G. J. Nossal, D. M. Tarlinton, EMBO J. 16, 2996 (1997). 22. E. M. Carrington et al., Proc. Natl. Acad. Sci. U.S.A. 107, 10967 (2010). 23. J. M. Adams, S. Cory, Oncogene 26, 1324 (2007). 24. L. Chen et al., Mol. Cell 17, 393 (2005). 25. S. N. Willis et al., Science 315, 856 (2007). 26. H. Toyama et al., Immunity 17, 329 (2002). 27. J. Roes, K. Rajewsky, J. Exp. Med. 177, 45 (1993). 28. D. Allen, T. Simon, F. Sablitzky, K. Rajewsky, A. Cumano, EMBO J. 7, 1995 (1988). 29. A. Cumano, K. Rajewsky, EMBO J. 5, 2459 (1986). 30. J. T. Opferman et al., Nature 426, 671 (2003). 31. C. D. Allen, T. Okada, J. G. Cyster, Immunity 27, 190 (2007). 32. D. Tarlinton, Nat. Rev. Immunol. 6, 785 (2006). 33. T. Oltersdorf et al., Nature 435, 677 (2005). 34. J. H. Cho-Vega et al., Hum. Pathol. 35, 1095 (2004). 35. D. Allen et al., Immunol. Rev. 96, 5 (1987). 36. This work was supported in part by grants from the National Health and Medical Research Council (NHMRC) Australia (356202 to D.M.T. and S.L.N. and 461221 to P.B. and A.S.), the Leukemia and Lymphoma Society (SCOR grant 7413), and the NIH (CA43540 and CA80188). D.M. T. and A.S. are supported by fellowships from the NHMRC; S.L. N. by a Pfizer Australia Research Fellowship; I.V. by the Olle Engkvist Byggmastare and Wenner-Gren Foundations; K.L. by a fellowship from the German Academic Exchange Service; P.B. by the Charles and Sylvia Viertel Charitable Foundation; and M.B. by Boehringer Ingelheim. DNA sequence data are available in GenBank (accession number HM804028-HM804084). We are indebted to the facilities of our respective institutes, particularly those responsible for animal husbandry and flow cytometry. We also acknowledge the assistance of L. O’Reilly for Western blot antibodies and the many helpful discussions with members of the Walter and Eliza Hall Institute B Cell Program. Author contributions are as follows: I.V. and D.M. T. designed the research; I.V. , K.L. , S.G. , V.P., S.C. , and P.J. performed experiments and contributed to interpretation and discussion; M.B. , P.B. , A.S. , and S.L. N. contributed to the design of experiments, interpretation of results, and drafting the manuscript; I.V. , K.L. , and V.P. analyzed data and prepared figures; and I.V. and D.M. T. wrote the manuscript.